Estimated reading time: seven (7) minutes
US/Silver Spring: FAonline Inc., a New York, New York establishment, recalls all current batch/lots of ForeverMen Dietary Supplements from the American marketplace due to reported Sildenafil and Tadalafil contamination, both FDA approved drugs for the treatment of Male Erectile Dysfunction (“ED”), Benign Prostatic Hyperplasia (“BPH”) and certain other medical conditions and in a class of drugs called Phosphodiesterase (“PDE-5”) Inhibitors with consequential risks of dangerous low blood pressure, injury and possible life-changing complications, all serious health and safety hazards.
FDA: https://tinyurl.com/49us8z5b
Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/forevermen-supplements-recalled
Additional information:
The US Food and Drug Administration (“FDA”) reports the following Dietary Supplement products are subject to this recall:
Filed under: Dietary Supplements, Drugs, Labeling or regulatory issues, Medical / Veterinary, Sildenafil, Tadalafil, US FDA | Tagged: Benign Prostatic Hyperplasia, Benign Prostatic Hyperplasia ("BPH"), Dietary Supplements, FAonline, ForeverMen, ForeverMen Dietary Supplements, Male Erectile Dysfunction ("ED"), Recalls Direct RIN: 18271-2024, undeclared Sildenafil hazard, undeclared-Tadalafil-hazard, US FDA, US Food and Drug Administration | Leave a comment »